Daktronics (DAKT) Faces Alta Fox Push for CEO/Chair Split, Poison Pill Removal, and Path to $40+ Share Price

Alta Fox (12% holder) is pushing for major governance and leadership changes at Daktronics, citing severe underperformance under CEO/Chair Reece Kurtenbach, nepotism, weak financial controls, and shareholder-unfriendly policies. It calls for board refreshment, splitting the CEO/Chair roles, removing the poison pill, replacing the CFO, and improving capital allocation and investor communication. Alta Fox argues these changes could unlock significant value, projecting the stock could more than double by FY28 .